HCPLive Network

Researchers Hope to Create 20 New Vaccines in Next Decade

They’re calling it the “Decade of Vaccines”.

Researchers writing in The Lancet say there is the potential to develop twenty vaccines in the next decade, as well as improve existing vaccines.

Their goal is to not only develop vaccinations for numerous diseases, such as leprosy, AIDS, and malaria, but to also make vaccinations for children a global priority, most especially for third world countries where diseases such as whooping cough and polio still wreak havoc.

"We need to find the requisite funds for the research and development of about twenty improved or novel vaccines in the next decade or beyond,” said the researchers.
According to these researchers and scientists, funding is critical—but so is trust and confidence in vaccines.

 “It is perhaps surprising that the public aren't always comfortable with immunization,” said Professor Richard Moxon Oxford University. "This call to action comes at a crucial time. In some communities, recent declines in vaccine uptake provide a stark reminder that public confidence and trust in immunisation is fragile and requires attention."

One such reminder was the recent outbreak of measles in Hennepin County, Minnesota, when an unvaccinated two-year contracted the disease after a trip to Kenya; the child lived in a neighborhood of Somalia descendents who were wary of vaccinating their children.

"It's complex. Perhaps one of the things that's most important is that vaccines are given to healthy people—often children,” stated Moxon. “Safety issues loom very large because there's very little awareness of many of the diseases that have been prevented by vaccines, such as polio and whooping cough."

Moxon was the brain behind the series of papers looking at the future of vaccine research.

The researchers are focusing on vaccinations such as AIDS and malaria, which they recognize as vaccines at the top of the list, but they are also looking to create vaccines for other diseases which may still be causing large health issues around the world.

 "We must also consider vaccines beyond classic infections, such as insulin-dependent diabetes, cancers and degenerative diseases,” said the scientists.

Moxon reported that he believed an AIDS vaccine is still many years away, but there is hope for an effective malaria vaccine within the next five years.

Maxon and fellow authors are issuing a “call to action” to developing countries and requesting that these nations shoulder more of the responsibility for financing vaccination programs.

"Most developing countries accord too low a priority to health in their budgets,” said Moxon. “They must be persuaded to take more of the burden themselves on behalf of their poorer citizens.”

Funding is critical and is still being debated for the Decade of Vaccines.

Further Reading
New York City has its first case of Ebola, confirmed tonight in Craig Spencer, MD, an emergency medicine specialist who recently returned from a volunteer stint caring for Ebola patients in Guinea, Africa for Doctors Without Borders. The New York City Department of Health and Mental Hygiene released a statement earlier today that Spencer, who works at New York Hospital/Columbia-Presbyterian in Manhattan had been rushed to Bellevue Hospital Center after he became ill with a high fever and gastro-intestinal symptoms. Mayor Bill Blasio provided further details at a news conference this evening.
Xi E. Zheng, MD, PhD, shares her views on young-onset colorectal cancer at 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
In what could be New York City’s first case of Ebola, a doctor identified by the NY Post as Craig Spencer, 33, MD an emergency medicine physician at New York Hospital/Columbia-Presbyterian was rushed to a special Ebola unit at city-run Bellevue Hospital Center in Manhattan. Spencer returned 10 days ago from a stint as a volunteer with Doctors without Borders, caring for Ebola victims in Guinea, one of three West African nations with major outbreaks.
Patients diagnosed with diabetic retinopathy may be able to get a sense of how their condition has progressed without having to leave the comfort of their own home.
Monitoring devices among intensive care patients set off 2.5 million alarms in one month at a U.S. hospital, a new study of "alarm fatigue" reveals. The research was published online Oct. 22 in PLOS ONE.
While in-office visits may still be best, virtual analysis may be a valuable option in atopic dermatitis care, according to a new study published online Oct. 22 in JAMA Dermatology.
After weight-loss surgery, some patients may be at risk for developing severe headaches, a new study suggests. The report was published online Oct. 22 in Neurology.
More Reading